
BCG has a long history of safe use in humans and is one of the best adjuvants known. The use of newer production methods may further reduce the risk of adverse side-effects. Early results with experimental animals have shown BCG to be an effective live recombinant delivery vehicle for several foreign vaccine antigens. Additional refinements to the safety and efficacy of the recombinant BCG vaccine vehicle are under development.
Recombination, Genetic, Vaccines, Synthetic, Genetic Vectors, Kanamycin Resistance, Drug Resistance, Microbial, Mycobacterium bovis, BCG Vaccine, Animals, Humans, Immunization, Safety
Recombination, Genetic, Vaccines, Synthetic, Genetic Vectors, Kanamycin Resistance, Drug Resistance, Microbial, Mycobacterium bovis, BCG Vaccine, Animals, Humans, Immunization, Safety
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 17 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
